Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Share-based Compensation (2023 - 2025)

Historic Share-based Compensation for 60 Degrees Pharmaceuticals (SXTP) over the last 3 years, with Q3 2025 value amounting to $34882.0.

  • 60 Degrees Pharmaceuticals' Share-based Compensation fell 9478.57% to $34882.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year decrease of 1841.02%. This contributed to the annual value of $3.6 million for FY2024, which is 10785.06% up from last year.
  • Latest data reveals that 60 Degrees Pharmaceuticals reported Share-based Compensation of $34882.0 as of Q3 2025, which was down 9478.57% from $34503.0 recorded in Q2 2025.
  • In the past 5 years, 60 Degrees Pharmaceuticals' Share-based Compensation registered a high of $3.6 million during Q4 2024, and its lowest value of $34503.0 during Q2 2025.
  • Over the past 3 years, 60 Degrees Pharmaceuticals' median Share-based Compensation value was $375130.0 (recorded in 2023), while the average stood at $864523.1.
  • In the last 5 years, 60 Degrees Pharmaceuticals' Share-based Compensation surged by 88809.62% in 2024 and then tumbled by 9874.66% in 2025.
  • 60 Degrees Pharmaceuticals' Share-based Compensation (Quarter) stood at $375130.0 in 2023, then skyrocketed by 857.91% to $3.6 million in 2024, then tumbled by 99.03% to $34882.0 in 2025.
  • Its last three reported values are $34882.0 in Q3 2025, $34503.0 for Q2 2025, and $142645.0 during Q1 2025.